← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Woomera Therapeutics, Inc.
Lebanon, NH
$2,005,396
Total funding
5
Grants
Funding over time
peak $491.1K · FY2006–14$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,005,396 · 5
By mechanism
R44$1,655,576 · 2
R43$349,820 · 3
Investigators at Woomera Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies$491,150
R44 · FY2012 · CA
Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies$475,993
R44 · FY2013 · CA
Treatment of Breast Cancer with MAG-1 Antibody$351,280
R44 · FY2010 · CA
Treatment of Breast Cancer with MAG-1 Antibody$337,153
R44 · FY2009 · CA
Synergy between MAG-1 and Cyclophosphamide for Treatment of Recurrent SCLC$149,819
R43 · FY2014 · CA
Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies$100,001
R43 · FY2011 · CA
MAG-1 Targeting of GRSA on Breast Cancer$100,000
R43 · FY2006 · CA